{"id":"https://openalex.org/W7224447908","doi":"https://doi.org/10.3389/fmicb.2026.1933938","title":"HIV-1 drug resistance and associated risk factors in antiretroviral therapy failure: a 2022\u20132024 surveillance in Huzhou, China","display_name":"HIV-1 drug resistance and associated risk factors in antiretroviral therapy failure: a 2022\u20132024 surveillance in Huzhou, China","publication_year":2026,"publication_date":"2026-10-29","ids":{"openalex":"https://openalex.org/W7224447908","doi":"https://doi.org/10.3389/fmicb.2026.1933938"},"language":"en","primary_location":{"id":"doi:10.3389/fmicb.2026.1933938","doi":"https://doi.org/10.3389/fmicb.2026.1933938","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmicb.2026.1933938","pdf_url":"https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2026.1933938/pdf","source":{"id":"https://openalex.org/S2484704948","display_name":"Frontiers in Microbiology","issn_l":"1664-302X","issn":["1664-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Microbiology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2026.1933938/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160119999","display_name":"Zhonghao Lu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhonghao Lu","raw_affiliation_strings":["Department of Clinical Microbiology, Huzhou Center for Disease Control and Prevention (Huzhou Municipal Health Inspection and Supervision Agency), Huzhou"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Microbiology, Huzhou Center for Disease Control and Prevention (Huzhou Municipal Health Inspection and Supervision Agency), Huzhou","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160143425","display_name":"Yijie Wu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yijie Wu","raw_affiliation_strings":["Department of Clinical Laboratory, The First People\u2019s Hospital of Huzhou, Huzhou"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Laboratory, The First People\u2019s Hospital of Huzhou, Huzhou","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002228509","display_name":"Yunfeng Zha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yunfeng Zha","raw_affiliation_strings":["Department of Clinical Microbiology, Huzhou Center for Disease Control and Prevention (Huzhou Municipal Health Inspection and Supervision Agency), Huzhou"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Microbiology, Huzhou Center for Disease Control and Prevention (Huzhou Municipal Health Inspection and Supervision Agency), Huzhou","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102827187","display_name":"Fenfen Dong","orcid":"https://orcid.org/0000-0002-0332-5383","observed_orcids":["https://orcid.org/0000-0002-0332-5383"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fenfen Dong","raw_affiliation_strings":["Department of Clinical Microbiology, Huzhou Center for Disease Control and Prevention (Huzhou Municipal Health Inspection and Supervision Agency), Huzhou"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Microbiology, Huzhou Center for Disease Control and Prevention (Huzhou Municipal Health Inspection and Supervision Agency), Huzhou","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036412770","display_name":"\u6768\u4e2d\u8363","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhongrong Yang","raw_affiliation_strings":["Department of HIV/TB Control and Prevention, Huzhou Center for Disease Control and Prevention (Huzhou Municipal Health Inspection and Supervision Agency), Huzhou"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of HIV/TB Control and Prevention, Huzhou Center for Disease Control and Prevention (Huzhou Municipal Health Inspection and Supervision Agency), Huzhou","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043875809","display_name":"Lei Ji","orcid":"https://orcid.org/0000-0001-6753-6465","observed_orcids":["https://orcid.org/0000-0001-6753-6465"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Lei Ji","raw_affiliation_strings":["Department of Clinical Microbiology, Huzhou Center for Disease Control and Prevention (Huzhou Municipal Health Inspection and Supervision Agency), Huzhou"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Microbiology, Huzhou Center for Disease Control and Prevention (Huzhou Municipal Health Inspection and Supervision Agency), Huzhou","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078466289","display_name":"\u6731\u6653\u5a1f","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Xiaojuan Zhu","raw_affiliation_strings":["Department of Clinical Microbiology, Huzhou Center for Disease Control and Prevention (Huzhou Municipal Health Inspection and Supervision Agency), Huzhou"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Microbiology, Huzhou Center for Disease Control and Prevention (Huzhou Municipal Health Inspection and Supervision Agency), Huzhou","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5043875809","https://openalex.org/A5078466289"],"corresponding_institution_ids":[],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.8705429,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-drug-resistance","display_name":"HIV-1 drug resistance","score":0.9829999804496765},{"id":"https://openalex.org/keywords/antiretroviral-therapy-failure","display_name":"antiretroviral therapy failure","score":0.9890000224113464},{"id":"https://openalex.org/keywords/resistance-associated-mutations","display_name":"resistance-associated mutations","score":0.8820000290870667},{"id":"https://openalex.org/keywords/nrti-resistance","display_name":"NRTI resistance","score":0.7919999957084656},{"id":"https://openalex.org/keywords/nnrti-resistance","display_name":"NNRTI resistance","score":0.9980000257492065},{"id":"https://openalex.org/keywords/protease-inhibitor-resistance","display_name":"protease inhibitor resistance","score":0.9359999895095825},{"id":"https://openalex.org/keywords/k65r","display_name":"K65R","score":0.9829999804496765},{"id":"https://openalex.org/keywords/k103n","display_name":"K103N","score":0.8220000267028809},{"id":"https://openalex.org/keywords/hiv-1-subtypes","display_name":"HIV-1 subtypes","score":0.925000011920929},{"id":"https://openalex.org/keywords/plasma-viral-load","display_name":"plasma viral load","score":0.8980000019073486},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.8309999704360962}],"concepts":[{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.7419999837875366},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6626999974250793},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.6352999806404114},{"id":"https://openalex.org/C2909970146","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Nucleoside Reverse Transcriptase Inhibitor","level":5,"score":0.5755000114440918},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.5627999901771545},{"id":"https://openalex.org/C761482","wikidata":"https://www.wikidata.org/wiki/Q118093","display_name":"Transmission (telecommunications)","level":2,"score":0.5343000292778015},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.5245000123977661},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.48010000586509705},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.461899995803833},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.45820000767707825},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.44920000433921814},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.4438000023365021},{"id":"https://openalex.org/C2778451633","wikidata":"https://www.wikidata.org/wiki/Q5629934","display_name":"HIV drug resistance","level":5,"score":0.44350001215934753},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4025000035762787},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.3564999997615814},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.3398999869823456},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.33329999446868896},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3264000117778778},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.31520000100135803},{"id":"https://openalex.org/C3019165603","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral treatment","level":5,"score":0.3077000081539154},{"id":"https://openalex.org/C2779690655","wikidata":"https://www.wikidata.org/wiki/Q374232","display_name":"Lentivirus","level":4,"score":0.3050999939441681},{"id":"https://openalex.org/C182707283","wikidata":"https://www.wikidata.org/wiki/Q7315622","display_name":"Resistance mutation","level":5,"score":0.2985000014305115},{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.29120001196861267},{"id":"https://openalex.org/C3018457394","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral drug","level":5,"score":0.2874999940395355},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.2863999903202057},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.27639999985694885},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.2646999955177307},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.26260000467300415},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.2619999945163727},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.2597000002861023},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.25760000944137573},{"id":"https://openalex.org/C97669555","wikidata":"https://www.wikidata.org/wiki/Q4118435","display_name":"Molecular epidemiology","level":4,"score":0.25529998540878296}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.3389/fmicb.2026.1933938","doi":"https://doi.org/10.3389/fmicb.2026.1933938","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmicb.2026.1933938","pdf_url":"https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2026.1933938/pdf","source":{"id":"https://openalex.org/S2484704948","display_name":"Frontiers in Microbiology","issn_l":"1664-302X","issn":["1664-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Microbiology","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:8d1fcf867ff64187b1cf4175caf3b4be","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/8d1fcf867ff64187b1cf4175caf3b4be","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Microbiology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fmicb.2026.1933938","doi":"https://doi.org/10.3389/fmicb.2026.1933938","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmicb.2026.1933938","pdf_url":"https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2026.1933938/pdf","source":{"id":"https://openalex.org/S2484704948","display_name":"Frontiers in Microbiology","issn_l":"1664-302X","issn":["1664-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Microbiology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7224447908.pdf","grobid_xml":"https://content.openalex.org/works/W7224447908.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1599825924","https://openalex.org/W2109142621","https://openalex.org/W2606783704","https://openalex.org/W3007779449","https://openalex.org/W4214606110","https://openalex.org/W4223971561","https://openalex.org/W4284678005","https://openalex.org/W4288809645","https://openalex.org/W4387831884","https://openalex.org/W4391451319","https://openalex.org/W4391485798","https://openalex.org/W4401884790","https://openalex.org/W4402077536","https://openalex.org/W4409877409","https://openalex.org/W4410193392","https://openalex.org/W4411599295","https://openalex.org/W6907235635","https://openalex.org/W7165379082"],"related_works":["https://openalex.org/W7131231413","https://openalex.org/W3012315384","https://openalex.org/W2582767837","https://openalex.org/W2006705337","https://openalex.org/W4214606110","https://openalex.org/W4393317977","https://openalex.org/W2961595930","https://openalex.org/W4394673731","https://openalex.org/W4394879649","https://openalex.org/W4396774768"],"abstract_inverted_index":{"Introduction":[0],"Characterizing":[1],"acquired":[2],"drug":[3,28,65],"resistance":[4,29,66],"(ADR)":[5],"profiles":[6],"among":[7,169],"individuals":[8],"experiencing":[9,55],"antiretroviral":[10,179],"therapy":[11],"(ART)":[12],"failure":[13],"is":[14],"critical":[15,173],"for":[16,157,176],"optimizing":[17,177],"clinical":[18],"management.":[19],"Methods":[20],"This":[21],"study":[22,163],"aimed":[23],"to":[24,42,89],"delineate":[25],"the":[26,72,98,165,183,191],"HIV-1":[27,151,188],"landscape,":[30],"specific":[31,150],"resistance-associated":[32],"mutations,":[33],"and":[34,46,64,106,115,126,137,149,181],"epidemiological":[35,47],"determinants":[36],"in":[37],"Huzhou,":[38],"China,":[39],"from":[40,51],"2022":[41],"2024.":[43],"Blood":[44],"samples":[45],"data":[48],"were":[49,62,69],"collected":[50],"184":[52],"HIV-1-infected":[53],"patients":[54],"ART":[56],"failure.":[57],"Viral":[58],"pol":[59],"region":[60],"sequences":[61],"amplified,":[63],"mutations":[67,131],"(DRMs)":[68],"interpreted":[70],"using":[71],"Stanford":[73],"University":[74],"HIV":[75],"Drug":[76],"Resistance":[77,88],"Database.":[78],"Results":[79],"The":[80,118],"overall":[81],"prevalence":[82,99],"of":[83,100,186],"ADR":[84],"was":[85],"44.0%":[86],"(81/184).":[87],"protease":[90],"inhibitors":[91,111],"(PIs)":[92],"remained":[93],"notably":[94],"low":[95],"at":[96],"1.6%,whereas":[97],"DRMs":[101,123],"associated":[102],"with":[103],"nucleoside":[104,108],"(NRTIs)":[105],"non":[107],"reverse":[109],"transcriptase":[110],"(NNRTIs)":[112],"reached":[113],"27.7%":[114],"41.8%,":[116],"respectively.":[117],"most":[119],"frequently":[120],"detected":[121],"NRTI-associated":[122],"included":[124],"M184V/I":[125],"K65R,":[127],"while":[128],"dominant":[129],"NNRTI-associated":[130],"comprised":[132],"V179D/E/F,":[133],"K103N,":[134],"V106I/L/M,":[135],"G190A/Q/S/T,":[136],"Y181C/L.":[138],"Furthermore,":[139],"multivariable":[140],"logistic":[141],"regression":[142],"identified":[143],"patient":[144],"age,":[145],"plasma":[146],"viral":[147],"load,":[148],"subtypes":[152],"as":[153],"independent":[154],"risk":[155],"factors":[156],"DRM":[158],"development.":[159],"Discussion":[160],"Ultimately,":[161],"this":[162],"elucidates":[164],"evolving":[166],"mutational":[167],"landscape":[168],"ART-experienced":[170],"individuals,":[171],"providing":[172],"evidence-based":[174],"insights":[175],"personalized":[178],"regimens":[180],"mitigating":[182],"onward":[184],"transmission":[185],"drug-resistant":[187],"variants":[189],"within":[190],"region.":[192]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2026-10-30T00:00:00"}